NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.35
-0.21 (-1.27%)
Dec 23, 2025, 4:00 PM EST - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $544.58 million as of December 23, 2025. Its market cap has increased by 61.75% in one year.
Market Cap
544.58M
Enterprise Value
555.75M
1-Year Change
61.75%
Ranking
Category
Stock Price
$16.35
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $544.58M, an increase of 38.47%. That is a compound annual growth rate of 7.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 544.58M | 63.05% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.86B |
| Johnson & Johnson | 499.50B |
| AbbVie | 402.80B |
| UnitedHealth Group | 294.54B |
| AstraZeneca | 284.34B |
| Novartis AG | 263.31B |
| Merck & Co. | 259.92B |
| Abbott Laboratories | 217.70B |